What Happened?
Burlington, MS-based SalioGen-Therapeutics Appointed Ray Tabibiazar as Chairman and Chief Executive Officer
About the Company
SalioGen Therapeutics is advancing the Exact DNA Integration Technology (EDIT) platform, the only genome engineering technology that is mammal-derived, for use in potentially curative non-viral gene therapy.
About the Person
Ray Tabibiazar is Chairman and Chief Executive Officer at SalioGen Therapeutics. Previously, Ray held various senior HR leadership roles in the industry.
Info Source
News
Short Profile